Patient HIV-1 strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavir.
Van Laethem
K
K
Witvrouw
M
M
Balzarini
J
J
Schmit
J C
JC
Sprecher
S
S
Hermans
P
P
Leal
M
M
Harrer
T
T
Ruiz
L
L
Clotet
B
B
Van Ranst
M
M
Desmyter
J
J
De Clercq
E
E
Vandamme
A M
AM
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D015224:Dideoxynucleosides / Q000494:pharmacology*; D004352:Drug Resistance, Microbial / Q000235:genetics*; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology*; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D009154:Mutation; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D000099227:Abacavir
D019380:Anti-HIV Agents; D015224:Dideoxynucleosides; D018894:Reverse Transcriptase Inhibitors; D000099227:Abacavir